Atrandi Biosciences champions microfluidics-based screening at PEGS 2023 conference in Portugal

VILNIUS, Lithuania | November 2023 –

Atrandi Biosciences recently participated at the Protein & Antibody Engineering Summit (PEGS) in Portugal, showcasing advancements in droplet microfluidics and semi-permeable capsule technologies. Zana Kapustina, Atrandi's Director of Product Management, took the stage to present these cutting-edge technologies and their transformative applications in antibody discovery and immune profiling sequencing.

In an engaging session attended by an audience of 70 esteemed professionals, Zana delved into the intricacies of droplet microfluidics, highlighting its role in enhancing precision and scalability in various functional screening applications. She also shed light on the immense potential of semi-permeable capsules, paving the way for more efficient immune profiling sequencing.

Atrandi Biosciences showcased its commitment to innovation at the event's exhibition area, where the Onyx and Styx microfluidic platforms were displayed. The PEGS 2023 experience was not only an opportunity for Atrandi Biosciences to demonstrate its technological prowess but also a chance for the team to engage with the vibrant community of antibody discovery pioneers.

Atrandi Biosciences extends its gratitude to the PEGS organizers and all participants for contributing to a dynamic and enriching event. For those who missed the chance to connect in person, further information about the showcased technologies and their applications can be explored on our website at https://atrandi.com/droplet-microfluidics